Patients with multiple sclerosis may benefit from over-the-counter therapy – Medical Xpress

June 30, 2017 Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit: Marvin 101/Wikipedia

Treatment options currently are limited for people suffering from secondary progressive multiple sclerosis. However, an OHSU pilot study suggests over-the-counter antioxidant lipoic acid holds promise in improving patients' lives.

The research was published June 28 in the journal Neuroimmunology & Neuroinflammation.

The randomized double-blind study involved 51 participants who completed the two-year trial. Twenty-seven people were given a 1,200-milogram daily dose of lipoic acid, with the remaining 24 participants given a placebo. Researchers are using the findings from the pilot trial to design the expanded multi-site clinical trial to begin later this year in Portland and other sites that have yet to be finalized.

"These are high doses," said lead author Rebecca Spain, M.D., M.S.P.H., an assistant professor of neurology in the OHSU School of Medicine. "And while it seems safe, we won't know whether it actually improves the lives of people with MS until we can replicate the results in the pilot study through a much bigger clinical trial. Fortunately, we're going to be able to answer that question with the participation of kind volunteers."

MS is a chronic condition that affects an estimated 2.3 million people worldwide. In MS, the sheath covering nerve fibers in the brain and spinal cord becomes damaged, slowing or blocking electrical signals from the brain reaching the eyes, muscles and other parts of the body.

The major finding of the pilot study involved measuring the degree to which lipoic acid arrested the rate of whole brain atrophy, as measured through magnetic resonance imaging.

The study revealed a 68 percent improvement over the placebo in slowing the rate of whole brain atrophy in patients with secondary progressive MS. For the sake of comparison, a clinical trial involving the recent FDA-approved pharmaceutical Ocrevus showed an 18 percent improvement over a placebo in slowing the rate of whole brain atrophy for patients with primary progressive forms of the disease.

In addition, the pilot study suggested improved walking times and fewer falls among study participants who took a daily dose of lipoic acid compared with those who received the placebo. Researchers are eager to test those outcomes in the larger clinical trial.

A companion study, published concurrently by Neuroimmunology & Neuroinflammation, measured the rate of absorption and clearance of lipoic acid through periodic blood tests of pilot study participants. The results will help to inform the design of additional clinical trials.

Lipoic acid was determined to be safe and well-tolerated by pilot study participants. Stomach upset was the most frequent side effect.

Explore further: Alpha-lipoic acid prevents kidney stones in mouse model of rare genetic disease

More information: Lipoic acid in secondary progressive MS, Neuroimmunology & Neuroinflammation, nn.neurology.org/content/4/5/e374.abstract

Alpha-lipoic acid, a dietary supplement widely available to consumers, prevented stone formation in a mouse model of cystinuria, a rare inherited disease that causes recurrent formation of painful and damaging kidney stones. ...

A UCL researcher is leading a phase 3 trial involving more than 1,000 people with multiple sclerosis (MS) to investigate whether simvastatin could become a treatment for the condition.

An antioxidant combination of vitamin E, vitamin C and -lipoic acid (E/C/ALA) was not associated with changes in some cerebrospinal fluid biomarkers related to Alzheimer disease in a randomized controlled trial, according ...

Probiotics may relieve symptoms of depression, as well as help gastrointestinal upset, research from McMaster University has found.

A dose of the drug simvastatin results in cognitive improvement in people with secondary progressive multiple sclerosis (SPMS), according to research published in The Lancet Neurology.

(HealthDay)Vitamin B6, but not vitamin B12, is associated with increased risk of hip fracture during extended follow-up, according to a study published online June 2 in the Journal of Bone and Mineral Research.

In a first-of-its-kind study, Mount Sinai researchers have discovered a novel technique to monitor laryngeal and vagus nerve function while patients are under anesthesia during otolaryngology and neurosurgery procedures. ...

Scientists have uncovered how nerve cells in the spinal cord are organised in precise patterns during embryo development - a finding that could give insight into regenerative medicine.

As brain-controlled robots enter everyday life, an article published in Science states that now is the time to take action and put in place guidelines that ensure the safe and beneficial use of direct brain-machine interaction.

The connection between slowed walking speed and declining mental acuity appears to arise in the right hippocampus, a finger-shaped region buried deep in the brain at ear-level, according to a 14-year study conducted by scientists ...

When you do something right, you can't learn anything from your success without a system in the brain for assigning credit to whatever action led to the desired outcome.

Mice, unlike cats and dogs, are able to move their whiskers to map out their surroundings, much as humans use their fingers to build a 3D picture of a darkened room.

Adjust slider to filter visible comments by rank

Display comments: newest first

Whenever you cite a science paper, it is imperative that you provide a link.

I need the link.

mitrich5@optonline.net

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Go here to read the rest:
Patients with multiple sclerosis may benefit from over-the-counter therapy - Medical Xpress